{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:00:14Z","timestamp":1792893614900,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jinf.2019.05.018","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T04:22:59Z","timestamp":1559017379000},"page":"75-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview"],"prefix":"10.1016","volume":"79","author":[{"given":"Loukas","family":"Kakoullis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Papachristodoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Chra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Panos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jinf.2019.05.018_bib0001","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1128\/IAI.01182-10","article-title":"Shiga toxin subtypes display dramatic differences in potency","volume":"79","author":"Fuller","year":"2011","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.jinf.2019.05.018_bib0002","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1365-2036.2006.03036.x","article-title":"Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection?","volume":"24","author":"Panos","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.jinf.2019.05.018_bib0003","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1371\/journal.pbio.0030255","article-title":"After 30 years of study, the bacterial SOS response still surprises us","volume":"3","author":"Michel","year":"2005","journal-title":"PLoS Biol"},{"issue":"June","key":"10.1016\/j.jinf.2019.05.018_bib0004","first-page":"1","article-title":"Shiga toxin in enterohemorrhagic E. coli: regulation and novel anti-virulence strategies","volume":"2","author":"Pacheco","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"10.1016\/j.jinf.2019.05.018_bib0005","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jama.288.8.996","article-title":"Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis","volume":"288","author":"Safdar","year":"2002","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.jinf.2019.05.018_bib0006","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/cid\/ciw099","article-title":"Shiga toxin-producing Escherichia coli infection, antibiotics, and risk of developing hemolytic uremic syndrome: a meta-analysis","volume":"62","author":"Freedman","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2019.05.018_bib0007","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1086\/318514","article-title":"Practice guidelines for the management of infectious diarrhea","volume":"32","author":"Guerrant","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2019.05.018_bib0008","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/cid\/cis299","article-title":"Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis","volume":"55","author":"Wong","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.jinf.2019.05.018_bib0009","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/cid\/cix669","article-title":"Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea","volume":"65","author":"Shane","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.jinf.2019.05.018_bib0010","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1089\/fpd.2013.1510","article-title":"Effects of subinhibitory concentrations of antimicrobial agents on Escherichia coli O157:H7 Shiga toxin release and role of the SOS response","volume":"10","author":"Nassar","year":"2013","journal-title":"Foodborne Pathog Dis"},{"issue":"9","key":"10.1016\/j.jinf.2019.05.018_bib0011","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1128\/AAC.01783-09","article-title":"Different classes of antibiotics differentially influence Shiga toxin production","volume":"54","author":"McGannon","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.jinf.2019.05.018_bib0012","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1086\/596509","article-title":"Gnotobiotic piglet infection model for evaluating the safe use of antibiotics against Escherichia coli O157:H7 infection","volume":"199","author":"Zhang","year":"2009","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.jinf.2019.05.018_bib0013","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1128\/IAI.00060-09","article-title":"Shiga toxin 2 is specifically released from bacterial cells by two different mechanisms","volume":"77","author":"Shimizu","year":"2009","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.jinf.2019.05.018_bib0014","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1086\/466536","article-title":"Non-O157 Shiga toxin\u2013producing Escherichia coli infections in the United States, 1983\u20132002","volume":"192","author":"Brooks","year":"2005","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2019.05.018_bib0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF01704889","article-title":"Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin I","volume":"20","author":"Walterspiel","year":"1992","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2019.05.018_bib0016","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s100960050181","article-title":"Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli 0157 following exposure to subinhibitory concentrations of antimicrobial agents","volume":"17","author":"Grif","year":"1998","journal-title":"Eur J Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2019.05.018_bib0017","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1574-695X.1999.tb01376.x","article-title":"Chemotherapy for enterohemorrhagic Escherichia coli O157:H infection in a mouse model","volume":"26","author":"Yoshimura","year":"1999","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"1","key":"10.1016\/j.jinf.2019.05.018_bib0018","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/fpd.2009.0311","article-title":"Effects of ampicillin, gentamicin, and cefotaxime on the release of Shiga toxins from Shiga toxin\u2013producing Escherichia coli isolated during a diarrhea episode in Faisalabad, Pakistan","volume":"7","author":"Mohsin","year":"2010","journal-title":"Foodborne Pathog Dis"},{"issue":"6","key":"10.1016\/j.jinf.2019.05.018_bib0019","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1128\/AAC.06315-11","article-title":"Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104:H4 strain","volume":"56","author":"Bielaszewska","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2019.05.018_bib0020","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2180-12-160","article-title":"Therapeutic concentrations of antibiotics inhibit Shiga toxin release from enterohemorrhagic E. coli O104:H4 from the 2011 German outbreak","volume":"12","author":"Corogeanu","year":"2012","journal-title":"BMC Microbiol"},{"issue":"2","key":"10.1016\/j.jinf.2019.05.018_bib0021","first-page":"119","article-title":"Colistin inhibits E. coli O157:H7 Shiga-like toxin release, binds endotoxins and protects vero cells","volume":"39","author":"Percivalle","year":"2016","journal-title":"New Microbiol"},{"issue":"9","key":"10.1016\/j.jinf.2019.05.018_bib0022","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1128\/JCM.00871-08","article-title":"Subtype-specific suppression of Shiga toxin 2 released from Escherichia coli upon exposure to protein synthesis inhibitors","volume":"46","author":"Pedersen","year":"2008","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.jinf.2019.05.018_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058959","article-title":"Investigation of encephalopathy caused by Shiga toxin 2c-producing Escherichia coli infection in mice","volume":"8","author":"Amran","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.jinf.2019.05.018_bib0024","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1128\/AAC.01397-06","article-title":"Rifaximin does not induce toxin production or phage-mediated lysis of Shiga toxin-producing Escherichia coli","volume":"51","author":"Ochoa","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.jinf.2019.05.018_bib0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jobm.3620350112","article-title":"Thermally-induced cell lysis in Escherichia coli K12","volume":"35","author":"Membrillo-Hern\u00e1ndez","year":"1995","journal-title":"J Basic Microbiol"},{"issue":"7","key":"10.1016\/j.jinf.2019.05.018_bib0026","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1099\/jmm.0.008573-0","article-title":"Effects of fosfomycin on Shiga toxin-producing Escherichia coli: quantification of copy numbers of Shiga toxin-encoding genes and their expression levels using real-time PCR","volume":"58","author":"Ichinohe","year":"2009","journal-title":"J Med Microbiol"},{"issue":"2","key":"10.1016\/j.jinf.2019.05.018_bib0027","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijantimicag.2010.10.009","article-title":"Role of rifampicin in limiting Escherichia coli O157:H7 Shiga-like toxin expression and enhancement of survival of infected BALB\/c mice","volume":"37","author":"Rahal","year":"2011","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.jinf.2019.05.018_bib0028","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1476-0711-10-34","article-title":"Decrease in Shiga toxin expression using a minimal inhibitory concentration of rifampicin followed by bactericidal gentamicin treatment enhances survival of Escherichia coli O157:H7-infected BALB\/c mice","volume":"10","author":"Rahal","year":"2011","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"10","key":"10.1016\/j.jinf.2019.05.018_bib0029","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.11150\/kansenshogakuzasshi1970.73.1054","article-title":"Therapeutic effects of antibiotics against enterohemorrhagic Escherichia coli (EHEC) O157:H7 (O157) infection: in vivo analysis using germfree mice","volume":"73","author":"Sawamura","year":"1999","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.jinf.2019.05.018_bib0030","doi-asserted-by":"crossref","unstructured":"Kurioka T., Yunou Y., Harada H., Kita E.Efficacy of antibiotic therapy for infection with Shiga-like toxin-producing Escherichia coli O157\u202f: H7 in mice with protein-calorie malnutrition. 1999:561\u2013571. doi:10.1007\/s100960050348.","DOI":"10.1007\/s100960050348"},{"key":"10.1016\/j.jinf.2019.05.018_bib0031","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.micpath.2013.09.008","article-title":"Proposal for effective treatment of Shiga toxin-producing Escherichia coli infection in mice","volume":"65","author":"Amran","year":"2013","journal-title":"Microb Pathog"},{"issue":"5","key":"10.1016\/j.jinf.2019.05.018_bib0032","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0924-8579(03)00007-4","article-title":"Treatment with rokitamycin suppresses the lethality in a murine model of Escherichia coli O157:H7 infection","volume":"21","author":"Hiramatsu","year":"2003","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.jinf.2019.05.018_bib0033","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0022-3476(05)81209-0","article-title":"Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis","volume":"121","author":"Proulx","year":"1992","journal-title":"J Pediatr"},{"issue":"4","key":"10.1016\/j.jinf.2019.05.018_bib0034","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1681\/ASN.2004100861","article-title":"Hemolytic uremic syndrome","volume":"16","author":"Noris","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jinf.2019.05.018_bib0035","unstructured":"Lee R.W., Robert R.S., Davia H.M.S., Harry M.B., Joy W.G., Betty D.R., et al. The New England Journal of Medicine Downloaded from nejm.org by William Marler on February 8, 2012. For personal use only. No other uses without permission. From the NEJM Archive. Copyright \u00a9 2010 Massachusetts Medical Society. All rights reserved. 2010."},{"issue":"4","key":"10.1016\/j.jinf.2019.05.018_bib0036","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3201\/eid1104.040833","article-title":"Childhood hemolytic uremic syndrome, United Kingdom and Ireland","volume":"11","author":"Remis","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"18","key":"10.1016\/j.jinf.2019.05.018_bib0037","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1001\/archinternmed.2010.346","article-title":"Hemolytic uremic syndrome after an Escherichia coli O111 outbreak","volume":"170","author":"Piercefield","year":"2010","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.jinf.2019.05.018_bib0038","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/INF.0b013e31823096a8","article-title":"Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota","volume":"31","author":"Smith","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.jinf.2019.05.018_bib0039","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009933","article-title":"Disease severity of Shiga toxin-producing E. coli O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, 2009-2012","volume":"6","author":"Launders","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.jinf.2019.05.018_bib0040","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jpeds.2016.09.013","article-title":"Province-wide review of pediatric Shiga toxin-producing Escherichia coli case management","volume":"180","author":"Freedman","year":"2017","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.jinf.2019.05.018_bib0041","doi-asserted-by":"crossref","first-page":"442","DOI":"10.7883\/yoken.65.442","article-title":"Does levofloxacin induce hemolytic uremic syndrome in patients infected with verotoxin-producing Escherichia coli O157 infections?","volume":"65","author":"Ohnishi","year":"2012","journal-title":"Jpn J Infect Dis"},{"issue":"12","key":"10.1016\/j.jinf.2019.05.018_bib0042","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.3201\/eid1112.050607","article-title":"Hemolytic uremic syndrome risk and Escherichia coli O157:H7","volume":"11","author":"Tserenpuntsag","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2019.05.018_bib0043","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/003693300204700505","article-title":"Three years experience of adults admitted to hospital in north-east Scotland with E. coli O157","volume":"47","author":"Cadwgan","year":"2002","journal-title":"Scott Med J"},{"issue":"12","key":"10.1016\/j.jinf.2019.05.018_bib0044","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM198303243081203","article-title":"Hemorrhagic colitis associated with a rare Escherichia coli serotype","volume":"308","author":"Riley","year":"1983","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jinf.2019.05.018_bib0045","doi-asserted-by":"crossref","first-page":"624","DOI":"10.7326\/0003-4819-101-5-624","article-title":"Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7","volume":"101","author":"Remis","year":"1984","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.jinf.2019.05.018_bib0046","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/infdis\/154.4.631","article-title":"Escherichia coli O157: H7 diarrhea in a nursing home: clinical, epidemiological, and pathological findings","volume":"154","author":"Ryan","year":"1986","journal-title":"J Infect Dis"},{"issue":"24","key":"10.1016\/j.jinf.2019.05.018_bib0047","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1001\/jama.1988.03720240029030","article-title":"Escherichia coli O157:H7, an emerging gastrointestinal pathogen. Results of a one-year, prospective, population-based study","volume":"259","author":"MacDonald","year":"1988","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jinf.2019.05.018_bib0048","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-109-9-705","article-title":"Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum","volume":"109","author":"Griffin","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jinf.2019.05.018_bib0049","doi-asserted-by":"crossref","unstructured":"Ostroff S.M., Kobayashi J.M., Lewis J.H.Infections with Escherichia coli O157:H7 in Washington state \u2013 the 1st year of statewide disease surveillance. 1989;262(3):355\u2013359.","DOI":"10.1001\/jama.1989.03430030043031"},{"issue":"1","key":"10.1016\/j.jinf.2019.05.018_bib0050","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1542\/peds.100.1.e12","article-title":"Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections","volume":"100","author":"Bell","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.jinf.2019.05.018_bib0051","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/515258","article-title":"A nationwide case-control study of Escherichia coli O157:H7 infection in the United States","volume":"177","author":"Slutsker","year":"1998","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.jinf.2019.05.018_bib0052","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1086\/322598","article-title":"The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients","volume":"33","author":"Dundas","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2019.05.018_bib0053","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1542\/peds.103.1.e2","article-title":"Epidemic of gastrointestinal tract infection including hemorrhagic colitis attributable to Shiga toxin 1-producing Escherichia coli O118:H2 at a junior high school in Japan","volume":"103","author":"Hashimoto","year":"1999","journal-title":"Pediatrics"},{"issue":"24","key":"10.1016\/j.jinf.2019.05.018_bib0054","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1056\/NEJM198712103172403","article-title":"A severe outbreak of Escherichia coli O157:H7\u2013associated hemorrhagic colitis in a nursing home","volume":"317","author":"Carter","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2019.05.018_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-3476(05)81600-2","article-title":"Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157: H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations","volume":"116","author":"Pavia","year":"1990","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.jinf.2019.05.018_bib0056","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1099\/jmm.0.015560-0","article-title":"Role and clinical course of verotoxigenic Escherichia coli infections in childhood acute diarrhoea in Argentina","volume":"59","author":"Rivero","year":"2010","journal-title":"J Med Microbiol"},{"issue":"26","key":"10.1016\/j.jinf.2019.05.018_bib0057","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJM200006293422601","article-title":"The risk of the hemolytic\u2013uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections","volume":"342","author":"Wong","year":"2000","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.jinf.2019.05.018_bib0058","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1056\/NEJM199010253231703","article-title":"The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota","volume":"323","author":"Martin","year":"1990","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jinf.2019.05.018_bib0059","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0022-3476(05)81609-9","article-title":"Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome","volume":"116","author":"Cimolai","year":"1990","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.jinf.2019.05.018_bib0060","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s15010-012-0387-6","article-title":"Ciprofloxacin reduces the risk of hemolytic uremic syndrome in patients with Escherichia coli O104:H4-associated diarrhea","volume":"41","author":"Geerdes-Fenge","year":"2013","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2019.05.018_bib0061","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1442-200X.1999.4121038.x","article-title":"Effect of early oral fluoroquinolones in hemorrhagic colitis due to Escherichia coli O157:H7","volume":"41","author":"Shiomi","year":"1999","journal-title":"Periatr Int"},{"issue":"51 Suppl","key":"10.1016\/j.jinf.2019.05.018_bib0062","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.7883\/yoken1952.51.Supplement1_S124","article-title":"Strategy to prevent the progression of enterohemorrhagic Escherichia coli O157 infection to hemolytic uremic syndrome","author":"Takeda","year":"1998","journal-title":"Jpn J Med Sci Biol"},{"issue":"2","key":"10.1016\/j.jinf.2019.05.018_bib0063","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1442-200X.1999.4121041.x","article-title":"Clinical experiences in Sakai City hospital during the massive outbreak of enterohemorrhagic Escherichia coli O157 infections in Sakai City, 1996","volume":"41","author":"Fukushima","year":"1999","journal-title":"Pediatr Int"},{"issue":"6","key":"10.1016\/j.jinf.2019.05.018_bib0064","first-page":"357","article-title":"Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection","volume":"52","author":"Ikeda","year":"1999","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jinf.2019.05.018_bib0065","series-title":"Enterohaemorrhagic Escherichia coli in Japan \u2013 Update","year":"2015"},{"issue":"5","key":"10.1016\/j.jinf.2019.05.018_bib0066","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ijantimicag.2015.08.006","article-title":"A role for fosfomycin treatment in children for prevention of haemolytic-uraemic syndrome accompanying Shiga toxin-producing Escherichia coli infection","volume":"46","author":"Tajiri","year":"2015","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"10.1016\/j.jinf.2019.05.018_bib0067","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s10156-011-0336-9","article-title":"Encephalopathy, disseminated intravascular coagulation, and hemolytic-uremic syndrome after infection withenterohemorrhagic Escherichia coli O111","volume":"18","author":"Matano","year":"2012","journal-title":"J Infect Chemother"},{"issue":"Suppl. 112","key":"10.1016\/j.jinf.2019.05.018_bib0068","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ki.2008.628","article-title":"An outbreak of diarrhoea-associated childhood hemolytic uremic syndrome: the Walkerton epidemic","volume":"75","author":"Matsell","year":"2009","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.jinf.2019.05.018_bib0069","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/ndt\/gft470","article-title":"Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab","volume":"29","author":"Delmas","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"Jul19 1","key":"10.1016\/j.jinf.2019.05.018_bib0070","doi-asserted-by":"crossref","first-page":"e4565","DOI":"10.1136\/bmj.e4565","article-title":"Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study","volume":"345","author":"Menne","year":"2012","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.jinf.2019.05.018_bib0071","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/infdis\/160.6.994","article-title":"Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections","volume":"160","author":"Ostroff","year":"1989","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2019.05.018_bib0072","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1128\/JCM.03617-13","article-title":"Real-time whole-genome sequencing for routine typing, surveillance, and outbreak detection of verotoxigenic Escherichia coli","volume":"52","author":"Joensen","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"May","key":"10.1016\/j.jinf.2019.05.018_bib0073","first-page":"1","article-title":"Implementation of whole genome sequencing (WGS) for identification and characterization of Shiga toxin-producing Escherichia coli (STEC) in the United States","volume":"7","author":"Lindsey","year":"2016","journal-title":"Front Microbiol"},{"issue":"7","key":"10.1016\/j.jinf.2019.05.018_bib0074","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022751","article-title":"Prospective genomic characterization of the german enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology","volume":"6","author":"Mellmann","year":"2011","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jinf.2019.05.018_bib0075","doi-asserted-by":"crossref","first-page":"e732","DOI":"10.1016\/j.ijid.2011.07.007","article-title":"The revival of fosfomycin","volume":"15","author":"Michalopoulos","year":"2011","journal-title":"Int J Infect Dis"},{"issue":"7","key":"10.1016\/j.jinf.2019.05.018_bib0076","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1128\/AAC.00447-16","article-title":"Potential use of fosfomycin-tromethamine for treatment of recurrent Campylobacter species enteritis","volume":"60","author":"Aguilar-Company","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.jinf.2019.05.018_bib0077","first-page":"522","article-title":"Antibacterial activity of fosfomycin against the causative bacteria isolated from bacterial enteritis","volume":"53","author":"Fukuyama","year":"2000","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.jinf.2019.05.018_bib0078","doi-asserted-by":"crossref","unstructured":"Thielman N.M., Guerrant R.L.Acute infectious diarrhea. 2004:38\u201347.","DOI":"10.1056\/NEJMcp031534"},{"key":"10.1016\/j.jinf.2019.05.018_bib0079","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.rvsc.2015.08.005","article-title":"Gastric stability and oral bioavailability of colistin sulfate in pigs challenged or not with Escherichia coli O149: F4 (K88)","volume":"102","author":"Rhouma","year":"2015","journal-title":"Res Vet Sci"},{"issue":"10","key":"10.1016\/j.jinf.2019.05.018_bib0080","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/jama.290.10.1337","article-title":"Effect of an oral Shiga toxin\u2013binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial","volume":"290","author":"Trachtman","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jinf.2019.05.018_bib0081","doi-asserted-by":"crossref","unstructured":"Dowling T.C., Chavaillaz P.A., Young D.G., Melton-celsa A., Brien A.O., Edelman R., et al. Phase 1 safety and pharmacokinetic study of chimeric murine-human monoclonal antibody c \u03b1 Stx2 administered intravenously to healthy adult volunteers phase 1 safety and pharmacokinetic study of chimeric murine-human monoclonal antibody c \u03b1 Stx2 administer. 2005;49(5):1\u20136. doi:10.1128\/AAC.49.5.1808.","DOI":"10.1128\/AAC.49.5.1808-1812.2005"},{"issue":"2","key":"10.1016\/j.jinf.2019.05.018_bib0082","doi-asserted-by":"crossref","DOI":"10.3390\/toxins9020049","article-title":"Efficacy of urtoxazumab (TMA-15 humanized monoclonal antibody specific for Shiga toxin 2) against post-diarrheal neurological sequelae caused by Escherichia coli O157:H7 infection in the neonatal gnotobiotic piglet model","volume":"9","author":"Moxley","year":"2017","journal-title":"Toxins (Basel)"},{"issue":"4","key":"10.1016\/j.jinf.2019.05.018_bib0083","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1128\/IAI.01099-10","article-title":"Virulence inhibition by zinc in Shiga-toxigenic Escherichia coli","volume":"79","author":"Crane","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2019.05.018_bib0084","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1471-2180-14-145","article-title":"Zinc protects against Shiga-toxigenic Escherichia coli by acting on host tissues as well as on bacteria","volume":"14","author":"Crane","year":"2014","journal-title":"BMC Microbiol"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445319301628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445319301628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:28:03Z","timestamp":1759008483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445319301628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":84,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0163445319301628"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2019.05.018","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735894289.793565314","asserted-by":"object"}]},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2019.05.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}]}}